PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfatc3
|
ENSMUSG00000031902.11 | Nfatc3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nfatc3 | mm39_v1_chr8_+_106785434_106785472 | 0.16 | 1.7e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_-_96917804 | 14.79 |
ENSMUST00000231039.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr3_+_137923521 | 14.46 |
ENSMUST00000090171.7
|
Adh7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
chr3_-_82957104 | 12.78 |
ENSMUST00000048246.5
|
Fgb
|
fibrinogen beta chain |
chr14_+_40827317 | 11.71 |
ENSMUST00000047286.7
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr14_+_40827108 | 11.33 |
ENSMUST00000224514.2
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr1_+_172525613 | 10.10 |
ENSMUST00000038495.5
|
Crp
|
C-reactive protein, pentraxin-related |
chr6_+_21986445 | 9.81 |
ENSMUST00000115382.8
|
Cped1
|
cadherin-like and PC-esterase domain containing 1 |
chr6_+_21985902 | 9.28 |
ENSMUST00000115383.9
|
Cped1
|
cadherin-like and PC-esterase domain containing 1 |
chr14_+_40826970 | 8.28 |
ENSMUST00000225720.2
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr12_+_8027767 | 8.24 |
ENSMUST00000037520.14
|
Apob
|
apolipoprotein B |
chr13_+_30520416 | 8.23 |
ENSMUST00000222503.2
ENSMUST00000222370.2 ENSMUST00000066412.8 ENSMUST00000223201.2 |
Agtr1a
|
angiotensin II receptor, type 1a |
chr10_+_21253190 | 8.03 |
ENSMUST00000042699.14
|
Aldh8a1
|
aldehyde dehydrogenase 8 family, member A1 |
chr15_+_10249646 | 7.84 |
ENSMUST00000134410.8
|
Prlr
|
prolactin receptor |
chr1_+_88139678 | 7.56 |
ENSMUST00000073049.7
|
Ugt1a1
|
UDP glucuronosyltransferase 1 family, polypeptide A1 |
chr15_+_9335636 | 7.51 |
ENSMUST00000072403.7
|
Ugt3a2
|
UDP glycosyltransferases 3 family, polypeptide A2 |
chr10_+_4561974 | 7.49 |
ENSMUST00000105590.8
ENSMUST00000067086.14 |
Esr1
|
estrogen receptor 1 (alpha) |
chr3_+_96432479 | 7.34 |
ENSMUST00000049208.11
|
Hjv
|
hemojuvelin BMP co-receptor |
chr1_+_171052623 | 7.24 |
ENSMUST00000111321.8
ENSMUST00000005824.12 ENSMUST00000111320.8 ENSMUST00000111319.2 |
Apoa2
|
apolipoprotein A-II |
chr6_-_21851827 | 6.60 |
ENSMUST00000202353.2
ENSMUST00000134635.2 ENSMUST00000123116.8 ENSMUST00000120965.8 ENSMUST00000143531.2 |
Tspan12
|
tetraspanin 12 |
chr15_+_10224052 | 6.32 |
ENSMUST00000128450.8
ENSMUST00000148257.8 ENSMUST00000128921.8 |
Prlr
|
prolactin receptor |
chr4_-_43523745 | 6.32 |
ENSMUST00000150592.2
|
Tpm2
|
tropomyosin 2, beta |
chr18_+_87774402 | 6.30 |
ENSMUST00000091776.7
|
Gm5096
|
predicted gene 5096 |
chr4_-_43523595 | 6.24 |
ENSMUST00000107914.10
|
Tpm2
|
tropomyosin 2, beta |
chr9_-_48516447 | 5.98 |
ENSMUST00000034808.12
ENSMUST00000119426.2 |
Nnmt
|
nicotinamide N-methyltransferase |
chr1_+_88015524 | 5.89 |
ENSMUST00000113139.2
|
Ugt1a8
|
UDP glucuronosyltransferase 1 family, polypeptide A8 |
chr10_+_87696339 | 5.85 |
ENSMUST00000121161.8
|
Igf1
|
insulin-like growth factor 1 |
chr16_+_22710785 | 5.84 |
ENSMUST00000023583.7
ENSMUST00000232098.2 |
Ahsg
|
alpha-2-HS-glycoprotein |
chr3_-_151953894 | 5.77 |
ENSMUST00000196529.5
|
Nexn
|
nexilin |
chr1_+_58152295 | 5.72 |
ENSMUST00000040999.14
ENSMUST00000162011.3 |
Aox3
|
aldehyde oxidase 3 |
chr15_+_102898966 | 5.70 |
ENSMUST00000001703.8
|
Hoxc8
|
homeobox C8 |
chr1_-_172722589 | 5.64 |
ENSMUST00000027824.7
|
Apcs
|
serum amyloid P-component |
chr18_+_11052458 | 5.52 |
ENSMUST00000047762.10
|
Gata6
|
GATA binding protein 6 |
chr4_-_62005498 | 5.39 |
ENSMUST00000107488.4
ENSMUST00000107472.8 ENSMUST00000084531.11 |
Mup3
|
major urinary protein 3 |
chr1_+_88022776 | 5.34 |
ENSMUST00000150634.8
ENSMUST00000058237.14 |
Ugt1a7c
|
UDP glucuronosyltransferase 1 family, polypeptide A7C |
chr8_+_48275178 | 5.30 |
ENSMUST00000079639.3
|
Cldn24
|
claudin 24 |
chr12_+_8027640 | 5.02 |
ENSMUST00000171271.8
ENSMUST00000037811.13 |
Apob
|
apolipoprotein B |
chr7_-_70010341 | 4.95 |
ENSMUST00000032768.15
|
Nr2f2
|
nuclear receptor subfamily 2, group F, member 2 |
chr11_+_96173355 | 4.94 |
ENSMUST00000125410.2
|
Hoxb8
|
homeobox B8 |
chr5_+_21748523 | 4.91 |
ENSMUST00000035651.6
|
Lrrc17
|
leucine rich repeat containing 17 |
chr1_+_87998487 | 4.88 |
ENSMUST00000073772.5
|
Ugt1a9
|
UDP glucuronosyltransferase 1 family, polypeptide A9 |
chr6_+_124470053 | 4.79 |
ENSMUST00000049124.10
|
C1rl
|
complement component 1, r subcomponent-like |
chr8_+_48277493 | 4.77 |
ENSMUST00000038693.8
|
Cldn22
|
claudin 22 |
chr4_-_129472328 | 4.76 |
ENSMUST00000052835.9
|
Fam167b
|
family with sequence similarity 167, member B |
chr1_-_180021218 | 4.74 |
ENSMUST00000159914.8
|
Coq8a
|
coenzyme Q8A |
chr2_-_64806106 | 4.66 |
ENSMUST00000156765.2
|
Grb14
|
growth factor receptor bound protein 14 |
chr8_+_104828253 | 4.61 |
ENSMUST00000034339.10
|
Cdh5
|
cadherin 5 |
chr4_-_107164315 | 4.60 |
ENSMUST00000126291.2
ENSMUST00000106748.2 ENSMUST00000129138.2 |
Dio1
|
deiodinase, iodothyronine, type I |
chr7_-_99276310 | 4.58 |
ENSMUST00000178124.3
|
Tpbgl
|
trophoblast glycoprotein-like |
chr6_+_48818567 | 4.49 |
ENSMUST00000203639.3
|
Tmem176a
|
transmembrane protein 176A |
chr5_-_103777145 | 4.30 |
ENSMUST00000031263.2
|
Slc10a6
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 6 |
chr5_-_18040713 | 4.28 |
ENSMUST00000197890.5
|
Cd36
|
CD36 molecule |
chr15_+_76579885 | 4.24 |
ENSMUST00000231028.2
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr11_+_72326337 | 4.23 |
ENSMUST00000076443.10
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr5_-_89605622 | 4.17 |
ENSMUST00000049209.13
|
Gc
|
vitamin D binding protein |
chr19_-_7943365 | 4.14 |
ENSMUST00000182102.8
ENSMUST00000075619.5 |
Slc22a27
|
solute carrier family 22, member 27 |
chr1_-_162694076 | 4.10 |
ENSMUST00000046049.14
|
Fmo1
|
flavin containing monooxygenase 1 |
chr16_+_17149235 | 4.09 |
ENSMUST00000023450.15
ENSMUST00000231884.2 |
Serpind1
|
serine (or cysteine) peptidase inhibitor, clade D, member 1 |
chr19_-_6947076 | 4.07 |
ENSMUST00000237074.2
|
Plcb3
|
phospholipase C, beta 3 |
chr17_-_71156639 | 4.06 |
ENSMUST00000134654.2
ENSMUST00000172229.8 ENSMUST00000127719.2 |
Tgif1
|
TGFB-induced factor homeobox 1 |
chr10_+_69048914 | 4.05 |
ENSMUST00000163497.8
ENSMUST00000164212.8 ENSMUST00000067908.14 |
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr5_-_18040647 | 4.02 |
ENSMUST00000082367.13
|
Cd36
|
CD36 molecule |
chrX_+_138464065 | 3.93 |
ENSMUST00000113027.8
|
Rnf128
|
ring finger protein 128 |
chr6_+_48818410 | 3.91 |
ENSMUST00000101426.11
ENSMUST00000168406.4 |
Tmem176a
|
transmembrane protein 176A |
chr15_-_91075933 | 3.90 |
ENSMUST00000069511.8
|
Abcd2
|
ATP-binding cassette, sub-family D (ALD), member 2 |
chr11_+_49500090 | 3.88 |
ENSMUST00000020617.3
|
Flt4
|
FMS-like tyrosine kinase 4 |
chr17_-_68311073 | 3.86 |
ENSMUST00000024840.12
|
Arhgap28
|
Rho GTPase activating protein 28 |
chr4_-_148021159 | 3.84 |
ENSMUST00000105712.2
|
Plod1
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
chr6_-_48818006 | 3.82 |
ENSMUST00000203229.3
|
Tmem176b
|
transmembrane protein 176B |
chr11_+_85723377 | 3.79 |
ENSMUST00000000095.7
|
Tbx2
|
T-box 2 |
chr4_-_82423985 | 3.78 |
ENSMUST00000107245.9
ENSMUST00000107246.2 |
Nfib
|
nuclear factor I/B |
chr11_-_80030735 | 3.77 |
ENSMUST00000136996.2
|
Tefm
|
transcription elongation factor, mitochondrial |
chr13_+_16189041 | 3.76 |
ENSMUST00000164993.2
|
Inhba
|
inhibin beta-A |
chr6_-_48818044 | 3.76 |
ENSMUST00000101429.11
ENSMUST00000204073.3 |
Tmem176b
|
transmembrane protein 176B |
chr6_-_48817914 | 3.73 |
ENSMUST00000164733.4
|
Tmem176b
|
transmembrane protein 176B |
chr10_-_105410280 | 3.67 |
ENSMUST00000061506.9
|
Tmtc2
|
transmembrane and tetratricopeptide repeat containing 2 |
chr16_+_35891991 | 3.67 |
ENSMUST00000164916.9
|
Ccdc58
|
coiled-coil domain containing 58 |
chr5_-_67256578 | 3.62 |
ENSMUST00000012664.11
|
Phox2b
|
paired-like homeobox 2b |
chr19_-_8382424 | 3.60 |
ENSMUST00000064507.12
ENSMUST00000120540.2 ENSMUST00000096269.11 |
Slc22a30
|
solute carrier family 22, member 30 |
chr3_+_108000425 | 3.56 |
ENSMUST00000151326.8
|
Gnat2
|
guanine nucleotide binding protein, alpha transducing 2 |
chr18_-_35760260 | 3.53 |
ENSMUST00000025212.8
|
Slc23a1
|
solute carrier family 23 (nucleobase transporters), member 1 |
chr6_-_48818430 | 3.53 |
ENSMUST00000205147.3
|
Tmem176b
|
transmembrane protein 176B |
chr12_-_101784727 | 3.48 |
ENSMUST00000222587.2
|
Fbln5
|
fibulin 5 |
chr15_+_10952418 | 3.48 |
ENSMUST00000022853.15
ENSMUST00000110523.2 |
C1qtnf3
|
C1q and tumor necrosis factor related protein 3 |
chr15_-_99717956 | 3.47 |
ENSMUST00000109024.9
|
Lima1
|
LIM domain and actin binding 1 |
chr14_+_19801333 | 3.45 |
ENSMUST00000022340.5
|
Nid2
|
nidogen 2 |
chr7_-_89176294 | 3.41 |
ENSMUST00000207932.2
|
Prss23
|
protease, serine 23 |
chr14_+_33807935 | 3.40 |
ENSMUST00000022519.15
|
Anxa8
|
annexin A8 |
chr11_+_98938137 | 3.39 |
ENSMUST00000140772.2
|
Igfbp4
|
insulin-like growth factor binding protein 4 |
chr1_+_171265103 | 3.39 |
ENSMUST00000043839.5
|
F11r
|
F11 receptor |
chr6_-_142647985 | 3.38 |
ENSMUST00000205202.3
ENSMUST00000073173.12 ENSMUST00000111771.8 |
Abcc9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
chr6_+_91661074 | 3.37 |
ENSMUST00000205480.2
ENSMUST00000206545.2 |
Slc6a6
|
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
chrX_-_8059597 | 3.37 |
ENSMUST00000143223.2
ENSMUST00000033509.15 |
Ebp
|
phenylalkylamine Ca2+ antagonist (emopamil) binding protein |
chr6_-_48422307 | 3.37 |
ENSMUST00000114563.8
ENSMUST00000114558.8 ENSMUST00000101443.10 |
Zfp467
|
zinc finger protein 467 |
chr5_+_16139909 | 3.35 |
ENSMUST00000196750.2
|
Cacna2d1
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
chr19_-_6947112 | 3.33 |
ENSMUST00000025912.10
|
Plcb3
|
phospholipase C, beta 3 |
chr6_-_48818302 | 3.33 |
ENSMUST00000203355.3
ENSMUST00000166247.8 |
Tmem176b
|
transmembrane protein 176B |
chr11_+_72326358 | 3.33 |
ENSMUST00000108499.2
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr2_+_85876205 | 3.32 |
ENSMUST00000213496.2
|
Olfr1034
|
olfactory receptor 1034 |
chr3_-_59038634 | 3.32 |
ENSMUST00000200358.2
ENSMUST00000197220.2 |
P2ry14
|
purinergic receptor P2Y, G-protein coupled, 14 |
chr6_-_142647944 | 3.30 |
ENSMUST00000100827.5
ENSMUST00000087527.11 |
Abcc9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
chr1_-_180021039 | 3.29 |
ENSMUST00000160482.8
ENSMUST00000170472.8 |
Coq8a
|
coenzyme Q8A |
chr3_-_57202546 | 3.26 |
ENSMUST00000196506.2
|
Tm4sf1
|
transmembrane 4 superfamily member 1 |
chr14_+_56062422 | 3.18 |
ENSMUST00000172271.9
|
Nfatc4
|
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
chr6_+_91661034 | 3.17 |
ENSMUST00000032185.9
|
Slc6a6
|
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
chr14_+_56062252 | 3.14 |
ENSMUST00000024179.6
|
Nfatc4
|
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
chr3_+_121761471 | 3.11 |
ENSMUST00000196479.5
ENSMUST00000197155.5 |
Arhgap29
|
Rho GTPase activating protein 29 |
chr16_-_21980200 | 3.10 |
ENSMUST00000115379.2
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr11_+_63023893 | 3.04 |
ENSMUST00000108700.2
|
Pmp22
|
peripheral myelin protein 22 |
chr9_+_77543776 | 3.02 |
ENSMUST00000057781.8
|
Klhl31
|
kelch-like 31 |
chr9_+_65172455 | 3.01 |
ENSMUST00000048762.8
|
Cilp
|
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase |
chr10_-_95251327 | 3.01 |
ENSMUST00000172070.8
ENSMUST00000150432.8 |
Socs2
|
suppressor of cytokine signaling 2 |
chr4_-_84593226 | 3.01 |
ENSMUST00000175800.8
ENSMUST00000176418.8 ENSMUST00000175969.8 ENSMUST00000176370.2 ENSMUST00000176947.8 ENSMUST00000102820.9 ENSMUST00000107198.9 ENSMUST00000175756.8 ENSMUST00000176691.8 |
Bnc2
|
basonuclin 2 |
chr13_+_113346193 | 3.00 |
ENSMUST00000038144.9
|
Esm1
|
endothelial cell-specific molecule 1 |
chr18_-_64794338 | 2.99 |
ENSMUST00000025482.10
|
Atp8b1
|
ATPase, class I, type 8B, member 1 |
chr10_-_95251145 | 2.97 |
ENSMUST00000119917.2
|
Socs2
|
suppressor of cytokine signaling 2 |
chr1_-_150341911 | 2.96 |
ENSMUST00000162367.8
ENSMUST00000161611.8 ENSMUST00000161320.8 ENSMUST00000159035.2 |
Prg4
|
proteoglycan 4 (megakaryocyte stimulating factor, articular superficial zone protein) |
chr1_-_93373145 | 2.88 |
ENSMUST00000186787.7
|
Hdlbp
|
high density lipoprotein (HDL) binding protein |
chr10_+_69048506 | 2.86 |
ENSMUST00000167384.8
|
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr17_+_37269468 | 2.83 |
ENSMUST00000040177.7
|
Polr1has
|
RNA polymerase I subunit H, antisense |
chr12_+_52550775 | 2.83 |
ENSMUST00000219443.2
|
Arhgap5
|
Rho GTPase activating protein 5 |
chrX_-_47602395 | 2.73 |
ENSMUST00000114945.9
ENSMUST00000037349.8 |
Aifm1
|
apoptosis-inducing factor, mitochondrion-associated 1 |
chr9_+_51959415 | 2.73 |
ENSMUST00000000590.16
ENSMUST00000238858.2 |
Rdx
|
radixin |
chr14_-_30645711 | 2.72 |
ENSMUST00000006697.17
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr12_+_111409087 | 2.71 |
ENSMUST00000109792.8
|
Tnfaip2
|
tumor necrosis factor, alpha-induced protein 2 |
chr6_+_29060215 | 2.69 |
ENSMUST00000069789.12
|
Lep
|
leptin |
chr3_-_59038031 | 2.66 |
ENSMUST00000091112.6
ENSMUST00000065220.13 |
P2ry14
|
purinergic receptor P2Y, G-protein coupled, 14 |
chr9_+_51959534 | 2.66 |
ENSMUST00000061352.11
|
Rdx
|
radixin |
chr3_-_145355725 | 2.63 |
ENSMUST00000029846.5
|
Ccn1
|
cellular communication network factor 1 |
chr2_+_155593030 | 2.61 |
ENSMUST00000029140.12
ENSMUST00000132608.2 |
Procr
|
protein C receptor, endothelial |
chr4_-_82423944 | 2.60 |
ENSMUST00000107248.8
ENSMUST00000107247.8 |
Nfib
|
nuclear factor I/B |
chr7_+_127311881 | 2.58 |
ENSMUST00000047393.7
|
Ctf1
|
cardiotrophin 1 |
chr9_+_7445822 | 2.55 |
ENSMUST00000034497.8
|
Mmp3
|
matrix metallopeptidase 3 |
chr9_+_107456086 | 2.55 |
ENSMUST00000149638.8
ENSMUST00000139274.8 ENSMUST00000130053.8 ENSMUST00000122985.8 ENSMUST00000127380.8 ENSMUST00000139581.2 |
Naa80
|
N(alpha)-acetyltransferase 80, NatH catalytic subunit |
chr17_+_28988271 | 2.55 |
ENSMUST00000233984.2
ENSMUST00000233460.2 |
Mapk13
|
mitogen-activated protein kinase 13 |
chr6_+_115398996 | 2.54 |
ENSMUST00000000450.5
|
Pparg
|
peroxisome proliferator activated receptor gamma |
chr1_+_178014983 | 2.54 |
ENSMUST00000161075.8
ENSMUST00000027783.14 |
Desi2
|
desumoylating isopeptidase 2 |
chr14_+_33807964 | 2.54 |
ENSMUST00000120077.2
|
Anxa8
|
annexin A8 |
chr17_+_24955647 | 2.52 |
ENSMUST00000101800.7
|
Msrb1
|
methionine sulfoxide reductase B1 |
chr18_-_35855383 | 2.52 |
ENSMUST00000133064.8
|
Ecscr
|
endothelial cell surface expressed chemotaxis and apoptosis regulator |
chr14_-_30645503 | 2.48 |
ENSMUST00000227995.2
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr17_+_24955613 | 2.45 |
ENSMUST00000115262.9
|
Msrb1
|
methionine sulfoxide reductase B1 |
chr17_+_37269513 | 2.45 |
ENSMUST00000173814.2
|
Polr1has
|
RNA polymerase I subunit H, antisense |
chr12_-_16660960 | 2.45 |
ENSMUST00000239165.2
ENSMUST00000111067.10 |
Lpin1
|
lipin 1 |
chr11_-_109886569 | 2.44 |
ENSMUST00000106669.3
|
Abca8b
|
ATP-binding cassette, sub-family A (ABC1), member 8b |
chr3_+_94284739 | 2.42 |
ENSMUST00000197040.5
|
Rorc
|
RAR-related orphan receptor gamma |
chr8_-_122379631 | 2.41 |
ENSMUST00000046386.5
|
Zcchc14
|
zinc finger, CCHC domain containing 14 |
chr4_-_148021217 | 2.41 |
ENSMUST00000019199.14
|
Plod1
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
chr8_-_94739469 | 2.41 |
ENSMUST00000053766.14
|
Amfr
|
autocrine motility factor receptor |
chr8_-_37200051 | 2.40 |
ENSMUST00000098826.10
|
Dlc1
|
deleted in liver cancer 1 |
chr11_-_47270201 | 2.40 |
ENSMUST00000077221.6
|
Sgcd
|
sarcoglycan, delta (dystrophin-associated glycoprotein) |
chr1_+_171041583 | 2.39 |
ENSMUST00000111328.8
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3 |
chr11_+_63023395 | 2.39 |
ENSMUST00000108701.8
|
Pmp22
|
peripheral myelin protein 22 |
chr8_-_41494890 | 2.38 |
ENSMUST00000051379.14
|
Mtus1
|
mitochondrial tumor suppressor 1 |
chr17_+_28988354 | 2.37 |
ENSMUST00000233109.2
ENSMUST00000004986.14 |
Mapk13
|
mitogen-activated protein kinase 13 |
chr1_-_169938060 | 2.36 |
ENSMUST00000027985.8
ENSMUST00000194690.6 |
Ddr2
|
discoidin domain receptor family, member 2 |
chr4_-_84593512 | 2.36 |
ENSMUST00000176612.8
|
Bnc2
|
basonuclin 2 |
chr11_-_35871300 | 2.33 |
ENSMUST00000018993.7
|
Wwc1
|
WW, C2 and coiled-coil domain containing 1 |
chr11_-_109886601 | 2.30 |
ENSMUST00000020948.15
|
Abca8b
|
ATP-binding cassette, sub-family A (ABC1), member 8b |
chr14_+_55797468 | 2.29 |
ENSMUST00000147981.2
ENSMUST00000133256.8 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr18_-_60866186 | 2.27 |
ENSMUST00000237885.2
|
Ndst1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr10_-_69048928 | 2.27 |
ENSMUST00000170048.2
|
A930033H14Rik
|
RIKEN cDNA A930033H14 gene |
chr9_+_88209250 | 2.27 |
ENSMUST00000034992.8
|
Nt5e
|
5' nucleotidase, ecto |
chr12_+_91367764 | 2.26 |
ENSMUST00000021346.14
ENSMUST00000021343.8 |
Tshr
|
thyroid stimulating hormone receptor |
chr17_-_48739874 | 2.26 |
ENSMUST00000046549.5
|
Apobec2
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
chr6_+_108637816 | 2.20 |
ENSMUST00000163617.2
|
Bhlhe40
|
basic helix-loop-helix family, member e40 |
chr6_-_129449739 | 2.18 |
ENSMUST00000112076.9
ENSMUST00000184581.3 |
Clec7a
|
C-type lectin domain family 7, member a |
chr11_+_67131403 | 2.18 |
ENSMUST00000170942.2
|
Myh4
|
myosin, heavy polypeptide 4, skeletal muscle |
chr17_+_43671314 | 2.17 |
ENSMUST00000226087.2
|
Adgrf5
|
adhesion G protein-coupled receptor F5 |
chr7_-_126062272 | 2.17 |
ENSMUST00000032974.13
|
Atp2a1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
chr3_-_59038539 | 2.15 |
ENSMUST00000198838.2
|
P2ry14
|
purinergic receptor P2Y, G-protein coupled, 14 |
chr17_-_45903494 | 2.14 |
ENSMUST00000163492.8
|
Slc29a1
|
solute carrier family 29 (nucleoside transporters), member 1 |
chr3_-_86455575 | 2.13 |
ENSMUST00000077524.4
|
Mab21l2
|
mab-21-like 2 |
chr3_-_20329823 | 2.11 |
ENSMUST00000011607.6
|
Cpb1
|
carboxypeptidase B1 (tissue) |
chr18_-_38130581 | 2.10 |
ENSMUST00000042944.9
|
Arap3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
chr5_+_91222470 | 2.09 |
ENSMUST00000031324.6
|
Ereg
|
epiregulin |
chr3_+_94284812 | 2.07 |
ENSMUST00000200009.2
|
Rorc
|
RAR-related orphan receptor gamma |
chr15_-_58828321 | 2.06 |
ENSMUST00000228067.2
|
Mtss1
|
MTSS I-BAR domain containing 1 |
chr2_-_148285450 | 2.06 |
ENSMUST00000099269.4
|
Cd93
|
CD93 antigen |
chr8_+_45960804 | 2.05 |
ENSMUST00000067065.14
ENSMUST00000124544.8 ENSMUST00000138049.9 ENSMUST00000132139.9 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr19_-_42741148 | 2.05 |
ENSMUST00000236659.2
ENSMUST00000076505.4 |
Pyroxd2
|
pyridine nucleotide-disulphide oxidoreductase domain 2 |
chr3_+_92272486 | 2.04 |
ENSMUST00000050397.2
|
Sprr2f
|
small proline-rich protein 2F |
chr6_-_142648027 | 2.01 |
ENSMUST00000204870.2
|
Abcc9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
chr1_-_66984178 | 2.01 |
ENSMUST00000027151.12
|
Myl1
|
myosin, light polypeptide 1 |
chr16_+_35892437 | 2.00 |
ENSMUST00000163352.9
ENSMUST00000231468.2 |
Ccdc58
|
coiled-coil domain containing 58 |
chr11_+_95557783 | 1.99 |
ENSMUST00000125172.8
ENSMUST00000036374.6 |
Phb
|
prohibitin |
chr15_+_3300249 | 1.98 |
ENSMUST00000082424.12
ENSMUST00000159158.9 ENSMUST00000159216.10 ENSMUST00000160311.3 |
Selenop
|
selenoprotein P |
chr5_-_67256388 | 1.97 |
ENSMUST00000174251.2
|
Phox2b
|
paired-like homeobox 2b |
chr15_-_77813123 | 1.96 |
ENSMUST00000109748.9
ENSMUST00000109747.9 ENSMUST00000100486.6 ENSMUST00000005487.12 |
Txn2
|
thioredoxin 2 |
chrX_+_21581135 | 1.94 |
ENSMUST00000033414.8
|
Slc6a14
|
solute carrier family 6 (neurotransmitter transporter), member 14 |
chr14_+_55797443 | 1.90 |
ENSMUST00000117236.8
|
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr19_+_40600836 | 1.90 |
ENSMUST00000134063.8
|
Entpd1
|
ectonucleoside triphosphate diphosphohydrolase 1 |
chr11_+_75546671 | 1.85 |
ENSMUST00000108431.3
|
Myo1c
|
myosin IC |
chr1_-_169938298 | 1.84 |
ENSMUST00000192312.6
|
Ddr2
|
discoidin domain receptor family, member 2 |
chr17_-_45903410 | 1.81 |
ENSMUST00000166119.8
|
Slc29a1
|
solute carrier family 29 (nucleoside transporters), member 1 |
chr11_+_67090878 | 1.80 |
ENSMUST00000124516.8
ENSMUST00000018637.15 ENSMUST00000129018.8 |
Myh1
|
myosin, heavy polypeptide 1, skeletal muscle, adult |
chr5_+_53747796 | 1.80 |
ENSMUST00000113865.5
|
Rbpj
|
recombination signal binding protein for immunoglobulin kappa J region |
chr18_+_4994600 | 1.79 |
ENSMUST00000140448.8
|
Svil
|
supervillin |
chr7_+_46496929 | 1.78 |
ENSMUST00000132157.2
ENSMUST00000210631.2 |
Ldha
|
lactate dehydrogenase A |
chr14_+_67470884 | 1.73 |
ENSMUST00000176161.8
|
Ebf2
|
early B cell factor 2 |
chr8_+_45960855 | 1.73 |
ENSMUST00000141039.8
|
Sorbs2
|
sorbin and SH3 domain containing 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.4 | 31.3 | GO:0009087 | methionine catabolic process(GO:0009087) |
3.6 | 14.5 | GO:0006069 | ethanol oxidation(GO:0006069) |
3.2 | 12.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.7 | 8.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
2.5 | 7.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
2.4 | 14.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
2.2 | 6.5 | GO:0001762 | beta-alanine transport(GO:0001762) taurine transport(GO:0015734) |
2.0 | 26.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
1.9 | 5.6 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.8 | 5.5 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
1.8 | 7.2 | GO:0046340 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) diacylglycerol catabolic process(GO:0046340) |
1.8 | 5.3 | GO:0006711 | estrogen catabolic process(GO:0006711) |
1.7 | 8.3 | GO:0070543 | response to linoleic acid(GO:0070543) |
1.6 | 6.4 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
1.6 | 6.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.6 | 4.7 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
1.3 | 13.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
1.3 | 6.5 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
1.3 | 10.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.3 | 6.3 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
1.2 | 7.5 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.2 | 5.0 | GO:0030091 | protein repair(GO:0030091) |
1.2 | 4.9 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
1.2 | 10.8 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
1.2 | 3.5 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
1.1 | 5.7 | GO:0009115 | xanthine catabolic process(GO:0009115) |
1.1 | 5.5 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
1.1 | 9.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
1.1 | 7.4 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
1.0 | 1.0 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
1.0 | 3.9 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.9 | 2.7 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
0.9 | 8.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.8 | 5.8 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.8 | 3.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.8 | 3.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.7 | 2.2 | GO:0090076 | maintenance of mitochondrion location(GO:0051659) relaxation of skeletal muscle(GO:0090076) |
0.7 | 5.4 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.6 | 2.5 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.6 | 3.8 | GO:0060596 | mammary placode formation(GO:0060596) |
0.6 | 3.0 | GO:1905068 | positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.6 | 2.3 | GO:0061295 | regulation of pronephros size(GO:0035565) mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
0.6 | 2.3 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.6 | 4.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 3.9 | GO:0015862 | uridine transport(GO:0015862) |
0.6 | 1.7 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.5 | 7.6 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.5 | 4.7 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.5 | 4.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.5 | 1.5 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) melanocyte proliferation(GO:0097325) |
0.5 | 4.5 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.4 | 3.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.4 | 0.9 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.4 | 1.3 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
0.4 | 1.7 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.4 | 12.9 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.4 | 1.7 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.4 | 2.1 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.4 | 1.6 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.4 | 2.0 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.4 | 1.2 | GO:1904092 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
0.4 | 3.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.4 | 3.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.4 | 3.9 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.4 | 1.9 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.4 | 3.0 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.4 | 2.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 1.1 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
0.4 | 1.5 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.3 | 2.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.3 | 5.1 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 1.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 3.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 8.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.3 | 1.3 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.3 | 3.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.3 | 2.3 | GO:1904587 | response to glycoprotein(GO:1904587) |
0.3 | 3.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.3 | 0.9 | GO:0036275 | response to 5-fluorouracil(GO:0036275) |
0.3 | 2.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 0.9 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 4.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 11.4 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.3 | 3.5 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.3 | 5.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 2.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 3.8 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.3 | 1.6 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.3 | 2.6 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.3 | 2.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.2 | 2.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 2.7 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.2 | 0.5 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 9.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 2.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 1.1 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 12.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 3.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 1.4 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.2 | 6.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 1.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.2 | 4.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 5.8 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.2 | 2.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 1.8 | GO:0019659 | glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.2 | 1.6 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.2 | 1.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 5.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 8.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 2.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 2.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 4.9 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 1.3 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.2 | 3.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.2 | 1.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 2.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 1.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 1.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 0.6 | GO:1903921 | renal protein absorption(GO:0097017) protein processing in phagocytic vesicle(GO:1900756) positive regulation of keratinocyte apoptotic process(GO:1902174) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.2 | 4.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.2 | 2.6 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 5.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.7 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 1.7 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.7 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.3 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.1 | 0.5 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 2.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 2.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 3.9 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 1.5 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 3.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.4 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.1 | 0.4 | GO:1990428 | miRNA transport(GO:1990428) |
0.1 | 0.6 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.3 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 1.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.7 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.3 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.1 | 0.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 1.6 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.5 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.8 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) |
0.1 | 5.1 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 1.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 2.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 2.2 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.9 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.4 | GO:0035694 | protein hexamerization(GO:0034214) mitochondrial protein catabolic process(GO:0035694) |
0.1 | 1.4 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 1.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 2.0 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 1.0 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 2.5 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.1 | 1.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.6 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 3.4 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.1 | 0.9 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) regulation of mitotic spindle assembly(GO:1901673) |
0.0 | 1.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 1.7 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 2.6 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 2.2 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 2.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.9 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 7.9 | GO:0007596 | blood coagulation(GO:0007596) |
0.0 | 3.4 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 2.5 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.0 | 0.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 2.7 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 2.7 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.9 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 2.7 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.0 | 7.4 | GO:0009952 | anterior/posterior pattern specification(GO:0009952) |
0.0 | 0.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 1.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.9 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 3.6 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 1.2 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 1.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 1.8 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.0 | 3.0 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.7 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 0.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 6.2 | GO:0015711 | organic anion transport(GO:0015711) |
0.0 | 0.3 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 2.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.2 | GO:0000303 | response to superoxide(GO:0000303) |
0.0 | 0.4 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 1.0 | GO:0035107 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.0 | 0.4 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.3 | GO:0016180 | snRNA processing(GO:0016180) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.3 | GO:0034359 | mature chylomicron(GO:0034359) |
1.4 | 12.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.3 | 3.8 | GO:0043512 | inhibin A complex(GO:0043512) |
1.1 | 7.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
1.0 | 8.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.9 | 3.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.8 | 12.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.7 | 8.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.6 | 5.8 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 7.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.5 | 2.4 | GO:0045160 | myosin I complex(GO:0045160) |
0.5 | 7.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.4 | 1.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.4 | 3.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 5.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 0.9 | GO:0097132 | cyclin D2-CDK6 complex(GO:0097132) |
0.3 | 0.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 0.9 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.3 | 2.2 | GO:0031673 | H zone(GO:0031673) |
0.3 | 2.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 1.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 1.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 1.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 0.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 25.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 0.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 4.0 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 2.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 1.7 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 3.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 4.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 3.5 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 2.7 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 2.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 3.4 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 8.3 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.7 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 5.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 1.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 2.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 1.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 4.6 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 2.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 5.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 11.6 | GO:0005901 | caveola(GO:0005901) |
0.1 | 1.3 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.5 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 3.9 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 3.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 7.8 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.9 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 4.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 2.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 3.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 4.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.8 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 1.4 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 17.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 3.8 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 1.2 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 1.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 48.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 3.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.2 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 5.8 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.5 | GO:0031901 | early endosome membrane(GO:0031901) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.8 | 31.3 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
4.8 | 14.5 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
2.9 | 8.7 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
2.8 | 14.2 | GO:0004925 | prolactin receptor activity(GO:0004925) |
2.7 | 8.2 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
2.5 | 7.5 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
2.2 | 17.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
2.2 | 6.5 | GO:0005368 | beta-alanine transmembrane transporter activity(GO:0001761) taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
2.2 | 6.5 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
1.8 | 7.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.7 | 8.3 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
1.4 | 5.7 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
1.3 | 3.8 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
1.3 | 6.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
1.2 | 3.5 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
1.2 | 6.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.1 | 4.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.0 | 4.2 | GO:1902271 | D3 vitamins binding(GO:1902271) |
1.0 | 13.3 | GO:0035473 | lipase binding(GO:0035473) |
1.0 | 3.0 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
1.0 | 6.0 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
1.0 | 5.8 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
0.8 | 4.2 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
0.8 | 31.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.7 | 4.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 2.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.6 | 2.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.6 | 7.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.6 | 1.7 | GO:0001607 | neuromedin U receptor activity(GO:0001607) |
0.6 | 8.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.6 | 3.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.5 | 2.7 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.5 | 9.8 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.5 | 1.5 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
0.5 | 3.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.5 | 2.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 3.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.4 | 0.9 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.4 | 1.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.4 | 1.2 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.4 | 1.2 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.4 | 4.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.4 | 2.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.3 | 4.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 3.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 1.7 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.3 | 5.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 3.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 3.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 0.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 0.8 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.3 | 6.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 2.2 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 18.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 1.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 2.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 2.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 4.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 6.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.9 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.2 | 0.9 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.2 | 6.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 1.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 1.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 9.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 4.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 1.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 1.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 1.7 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 8.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 2.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 1.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 6.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 2.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 4.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 4.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 7.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 3.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 3.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 2.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 8.0 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.9 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.4 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.1 | 3.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 5.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 3.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 3.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 12.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 2.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 1.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 1.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.3 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.1 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 1.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 1.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 1.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.4 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 1.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.9 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 2.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 1.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 8.3 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.9 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 1.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 9.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.0 | 1.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.6 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.1 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.0 | 1.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 1.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 2.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 4.4 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 1.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.6 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 4.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.5 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 3.7 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 0.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.0 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 5.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 3.2 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 2.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 10.0 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 2.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 2.4 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.0 | 0.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 3.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 5.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 2.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.5 | GO:0050699 | WW domain binding(GO:0050699) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 33.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.5 | 16.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 3.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 4.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 7.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 10.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 2.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 10.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 4.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 4.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 5.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 6.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 4.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 5.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 8.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 6.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 5.8 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 4.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 3.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 3.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 3.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 3.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 3.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 3.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 3.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.6 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 1.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 4.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 15.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 2.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 4.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 2.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 3.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 6.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 6.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 3.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 1.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.5 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 18.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.4 | 15.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.3 | 10.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.9 | 31.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.8 | 12.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.7 | 20.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 7.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 3.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.5 | 9.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.4 | 12.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 3.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 8.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 3.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 13.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 14.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 7.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 4.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 4.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 12.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 4.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 6.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 8.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 6.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 9.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 3.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 1.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 3.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 4.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 4.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 4.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 15.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 2.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 2.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 5.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 4.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 3.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 4.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 4.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 3.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 2.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 6.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.8 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 2.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 6.0 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.1 | 3.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 3.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 5.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 3.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 2.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 2.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 2.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 3.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 1.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 5.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 3.1 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 1.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 1.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 2.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |